{"favorite_id": 10233, "calc_type": "diagnostic_criteria", "dosing": false, "full_title_en": "Multiple Myeloma Diagnostic Criteria", "short_title_en": "Multiple Myeloma Diagnostic Criteria", "medium_description_en": "Diagnoses multiple myeloma, according to the International Myeloma Working Group (IMWG).", "short_description_en": "Multiple myeloma diagnosis.", "before_use": "", "instructions_en": "", "purpose_en": ["Diagnosis"], "disease_en": ["Multiple Myeloma"], "specialty_en": ["Radiation Oncology", "Internal Medicine", "Hospitalist Medicine", "Hematology and Oncology"], "chief_complaint_en": ["Extremity Pain", "Cancer"], "system_en": ["Oncologic", "Hematologic"], "search_abbreviation_en": ["Mm", "Multiple Myeloma Diagnostic Criteria (IMWG)", "multiple myeloma", "disease definition", "multiple myeloma disease definition", "myeloma", "imwg"], "slug": "multiple-myeloma-diagnostic-criteria", "seo": {"meta_description_en": "The Multiple Myeloma Diagnostic Criteria (IMWG) diagnosis multiple myeloma.", "keywords_en": "Mm, Multiple Myeloma Diagnostic Criteria (IMWG), multiple myeloma, disease definition, multiple myeloma disease definition, myeloma, imwg"}, "content": {"how_to_use": {"use_case_en": "<p>Do you use the&nbsp;Multiple Myeloma Diagnostic Criteria and want to contribute your expertise?&nbsp;<a href=\"https://www.mdcalc.com/join-us\" target=\"_blank\">Join</a>&nbsp;our contributor team!</p>", "pearls_pitfalls_en": "", "why_use_en": ""}, "next_steps": {"advice_en": "<p>Do you use the&nbsp;Multiple Myeloma Diagnostic Criteria and want to contribute your expertise?&nbsp;<a href=\"https://www.mdcalc.com/join-us\" target=\"_blank\">Join</a>&nbsp;our contributor team!</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p dir=\"ltr\">Selection of the appropriate criteria:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"439\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Criteria</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">(A) Clonal bone marrow plasma cells &ge;10% or (B) biopsy-proven bony or extramedullary plasmacytoma&nbsp;</p>\n<p dir=\"ltr\">AND</p>\n<p dir=\"ltr\">(C) &ge;1 myeloma defining event (C1 or C2):</p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">(C1) End organ damage attributable underlying plasma cell proliferative disorder, specifically:&nbsp;</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Hypercalcemia:</strong> serum calcium &gt;1 mg/dL (&gt;0.25 mmol/L) higher than upper limit of normal or &gt;11 mg/dL (&gt;2.75 mmol/L)</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Renal insufficiency:</strong> <calculator id=\"43\">creatinine clearance</calculator> &lt;40 mL per min or serum creatinine &gt;2 mg/dL (177 &mu;mol/L)</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Anemia:</strong>&nbsp;hemoglobin &gt;2 g/dL (20 g/L) below lower limit of normal, or hemoglobin &lt;10 g/dL (100 g/L)</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Bone lesions:</strong> &ge;1 osteolytic lesion on skeletal x-ray, CT, or PET-CT</p>\n</li>\n</ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">(C2) &ge;1 of the following biomarkers of malignancy:</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Clonal bone marrow plasma cells &ge;60%</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Involved:uninvolved sFLC ratio &ge;100</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&gt;1 focal lesion on MRI</p>\n</li>\n</ul>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n</div>", "more_info_en": "", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/25439696", "text": "Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538-48."}], "Other References": [], "Validation": [], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. Sundararajan V. Rajkumar", "qa_en": "", "creator_info": {"about_en": "<p>Sundararajan V. Rajkumar, MD, is a hematologist and oncologist at the Mayo Clinic in Rochester, Minnesota. He is also the editor-in-chief of the <i>Blood Cancer Journal</i> and the associate editor of the <i>European Journal of Hematology</i>. Dr. Rajkumar\u2019s primary research is focused on myeloma and related disorders.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-sundararajan-rajkumar.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Rajkumar+SV%5BAu%5D"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"subheading": "\u22651 of the following (A or B)", "subheading_instructions": "", "type": "subheading"}, {"type": "toggle", "label_en": "A. Clonal bone marrow plasma cells \u226510%", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "a"}, {"type": "toggle", "label_en": "B. Biopsy-proven bony or extramedullary plasmacytoma", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "b"}, {"subheading": "\u22651 myeloma defining event (C1 or C2)", "subheading_instructions": "C1. End organ damage attributable to underlying plasma cell disorder (\u22651 of the following):", "type": "subheading"}, {"type": "toggle", "label_en": "Hypercalcemia", "default": 0, "conditionality": "", "show_points": false, "tips_en": "Serum calcium >1 mg/dL (>0.25 mmol/L) higher than upper limit of normal or >11 mg/dL (>2.75 mmol/L)", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "c1"}, {"type": "toggle", "label_en": "Renal insufficiency", "default": 0, "conditionality": "", "show_points": false, "tips_en": "<calculator id = \"43\">Creatinine clearance</calculator> <40 mL per min or serum creatinine >2 mg/dL (177 \u03bcmol/L)", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "c2"}, {"type": "toggle", "label_en": "Anemia", "default": 0, "conditionality": "", "show_points": false, "tips_en": "Hemoglobin >2 g/dL (20 g/L) below lower limit of normal, or <10 g/dL (100 g/L)", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "c3"}, {"type": "toggle", "label_en": "Bone lesions", "default": 0, "conditionality": "", "show_points": false, "tips_en": "\u22651 osteolytic lesion on skeletal x-ray, CT, or PET-CT", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "c4"}, {"subheading": "", "subheading_instructions": "C2. \u22651 of the following biomarkers of malignancy:", "type": "subheading"}, {"type": "toggle", "label_en": "Clonal bone marrow plasma cells \u226560%", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "d1"}, {"type": "toggle", "label_en": "Involved:uninvolved <abbr title=\"Serum free light chain\">sFLC</abbr> ratio \u2265100", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "d2"}, {"type": "toggle", "label_en": ">1 focal lesion on MRI", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "d3"}], "md5": "", "related_calcs": [{"calcId": 10232, "short_title_en": "Multiple Myeloma Response Criteria", "slug": "multiple-myeloma-response-criteria"}, {"calcId": 3929, "short_title_en": "Asymptomatic Myeloma Prognosis", "slug": "asymptomatic-myeloma-prognosis"}, {"calcId": 3842, "short_title_en": "Revised Myeloma ISS", "slug": "revised-multiple-myeloma-international-staging-system-r-iss"}]}